Income Statement
Revenue$1.1B
Gross Profit$722.7M
Operating Income$362.6M
EBITDA$400.9M
Net Income$278.4M
IDXX
IDEXX Laboratories, Inc.
NMSSector: HealthcareIndustry: Diagnostics & Research
Valuation
Market Cap
$43.94B
Enterprise Value
$44.22B
P/E
41.1
TTMFwd P/E
33.7
1YP/B
28.4
P/S
9.9
TTMPEG
3.52
EV/EBITDA
28.6
EV/Revenue
9.9
FCF Yield
2.4%
EPS (TTM)
$13.56
Fwd EPS
$16.52
Book Value
$19.64
Market Data
Beta
1.54
Avg Volume
604K
Shares Out
78.9M
Float
78.6M
Short % Float
3.2%
Insider %
0.2%
Institutional %
96.2%
D/E
71.0
Current Ratio
1.1
ROE
72.9%
ROA
26.5%
Rev Growth
14.3%
Net Inc Growth
17.2%
Profit Margin
24.6%
Op Margin
31.8%
Gross Margin
62.1%
Total Cash
$200.5M
Total Debt
$1.11B
Financials
Latest period financial summary
Balance Sheet
Total Assets$3.4B
Current Assets$1.5B
Cash$200.5M
Total Liabilities$1.8B
Equity$1.6B
Total Debt$1.1B
Cash Flow
Operating CF$266.2M
Investing CF$-33.5M
Financing CF$-211.4M
Free Cash Flow$232.5M
Financial Trends
Revenue$1.1B
2022/122026/3
Net Income$278.4M
2022/122026/3
EBITDA$400.9M
2022/122026/3
Free Cash Flow$232.5M
2022/122026/3
Period Analysis
Margins & Ratios
| Metric | 2022/12 | 2023/12 | 2024/9 | 2024/12 | 2025/3 | 2025/6 | 2025/9 | 2025/12 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.7B | — | $3.9B | $998.4M | $1.1B | $1.1B | $4.3B |
| Gross Margin | +59.5% | +59.8% | — | +61.0% | +62.4% | +62.6% | +61.8% | +61.8% |
| EBITDA Margin | +30.0% | +33.3% | — | +32.6% | +35.2% | +36.9% | +35.5% | +35.0% |
| Operating Margin | +26.7% | +30.0% | — | +29.0% | +31.7% | +33.6% | +32.1% | +31.6% |
| Net Margin | +20.2% | +23.1% | — | +22.8% | +24.3% | +26.5% | +24.8% | +24.6% |
| Current Ratio | 0.89 | 1.57 | — | 1.31 | 1.16 | 1.11 | 1.18 | 1.23 |
| Debt / Equity | 2.41 | 0.72 | — | 0.62 | 0.73 | 0.85 | 0.71 | 0.61 |
| Net Debt / EBITDA | 1.34 | 0.50 | — | 0.55 | 2.55 | 2.62 | 2.31 | 0.53 |
| ROE | +111.6% | +56.9% | — | +55.7% | +16.8% | +20.2% | +17.6% | +66.0% |
| ROA | +24.7% | +25.9% | — | +27.0% | +7.6% | +8.8% | +8.1% | +31.6% |
| Leverage | 0.78 | 0.54 | — | 0.52 | 0.55 | 0.56 | 0.54 | 0.52 |
Company Profile
IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Employees
11K
Location
Westbrook, ME
Country
US
Golden Bazaar VerifiedUpdated: Jun 25, 2026Data Source: Golden Bazaar Verified · Updated: Jun 25, 2026
Sector Peers
Comparison Screen →Healthcare
Compare with similar companies in the same sector.
This page is prepared by Golden Bazaar using publicly available data. Not investment advice.